Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments

A Sensitive A  Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid

(2014) M. J. Savage et al.   JOURNAL OF NEUROSCIENCE

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

(2013) Michael W. Weiner et al.   Alzheimers & Dementia

Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection

(2013) Shannon L. Risacher et al.   Annual Review of Clinical Psychology

Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid- 1-42 and   Proteins as Alzheimer Disease Biomarkers

(2013) J.-H. Kang et al.   CLINICAL CHEMISTRY

Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations

(2013) J Cummings et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cerebrospinal fluid biomarkers for pathological processes in Alzheimerʼs disease

(2013) Christoffer Rosén et al.   CURRENT OPINION IN PSYCHIATRY

Cerebrospinal fluid α-synuclein levels in Parkinson's disease - changed or unchanged?

(2013) H. Zetterberg et al.   EUROPEAN JOURNAL OF NEUROLOGY

Fluid biomarkers in Alzheimer’s disease – current concepts

(2013) Christoffer Rosén et al.   Molecular Neurodegeneration

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation

(2013) Eugenio Barone et al.   NEUROBIOLOGY OF DISEASE

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

(2013) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

(2013) Eugenia Trushina et al.   PLoS One

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials

(2013) Krista L Moulder et al.   Alzheimers Research & Therapy

Plasma tau levels in Alzheimer's disease

(2013) Henrik Zetterberg et al.   Alzheimers Research & Therapy

Alterations in metabolic pathways and networks in Alzheimer’s disease

(2013) R Kaddurah-Daouk et al.   Translational Psychiatry

Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot

(2012) Harald Hampel et al.   Alzheimers & Dementia

Mass Spectrometry–Based Proteomics and Network Biology

(2012) Ariel Bensimon et al.   Annual Review of Biochemistry

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Analytical aspects of molecular Alzheimer’s disease biomarkers

(2012) Ulf Andreasson et al.   Biomarkers in Medicine

Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42

(2012) Niklas Mattsson et al.   Biomarkers in Medicine

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

(2012) Anne M Fagan et al.   Biomarkers in Medicine

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer’s disease

(2012) Ju-Hee Kang et al.   METHODS

Metabolic phenotyping in clinical and surgical environments

(2012) Jeremy K. Nicholson et al.   NATURE

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

(2012) Paola Picotti et al.   NATURE METHODS

From inherited to sporadic AD—crossing the biomarker bridge

(2012) Harald Hampel et al.   Nature Reviews Neurology

Evaluation of the Performance of Novel Aß Isoforms as Theragnostic Markers in Alzheimer’s Disease: From the Cell to the Patient

(2012) Erik Portelius et al.   Neurodegenerative Diseases

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

(2012) Thorlakur Jonsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

TREM2 Variants in Alzheimer's Disease

(2012) Rita Guerreiro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid

(2012) Christian Czech et al.   PLoS One

Metabolomics: the final frontier?

(2012) Timothy D Veenstra   Genome Medicine

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update

(2012) Rupasri Mandal et al.   Genome Medicine

The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception

(2011) Michael W. Weiner et al.   Alzheimers & Dementia

Mass spectrometry-based proteomics for systems biology

(2011) Eduard Sabidó et al.   CURRENT OPINION IN BIOTECHNOLOGY

Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

(2011) Niklas Mattsson et al.   NEUROMOLECULAR MEDICINE

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

(2011) Richard J. Perrin et al.   PLoS One

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

(2011) Rebecca Craig-Schapiro et al.   PLoS One

Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans

(2011) Henrik Zetterberg et al.   PLoS One

On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia

(2011) F. Geser et al.   PROGRESS IN NEUROBIOLOGY

Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease

(2011) Giuseppe Astarita et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Metabolomic changes in autopsy-confirmed Alzheimer's disease

(2010) Rima Kaddurah-Daouk et al.   Alzheimers & Dementia

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

(2010) Yu-Ichi Noto et al.   Amyotrophic Lateral Sclerosis

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

(2010) Rebecca Craig-Schapiro et al.   BIOLOGICAL PSYCHIATRY

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

(2010) Annika Thorsell et al.   BRAIN RESEARCH

Lipidomics: New Tools and Applications

(2010) Markus R. Wenk   CELL

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS

(2010) Valentina Albertini et al.   Proteomics Clinical Applications

A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

(2010) Erik Portelius et al.   Alzheimers Research & Therapy

A novel pathway for amyloid precursor protein processing

(2009) Erik Portelius et al.   NEUROBIOLOGY OF AGING

Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid

(2009) Erik Portelius et al.   Neurodegenerative Diseases

Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology

(2009) Farshid Noorbakhsh et al.   TRENDS IN NEUROSCIENCES

Biochemical markers in persons with preclinical familial Alzheimer disease

(2008) J. M. Ringman et al.   NEUROLOGY

Integrated Analysis of the Cerebrospinal Fluid Peptidome and Proteome

(2007) Alexandre Zougman et al.   JOURNAL OF PROTEOME RESEARCH

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease

(2007) A.H. Simonsen et al.   NEUROBIOLOGY OF AGING